{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:20Z","timestamp":1792511960794,"version":"4.5.0"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T00:00:00Z","timestamp":1223251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold><jats:styled-content>Purpose:<\/jats:styled-content>\u2002<\/jats:bold> Valproate (VPA) interferes with mitochondrial metabolism causing hyperammonemia, thereby shifting the balance reaction of glutamine (Gln)\/glutamate (Glu) toward Gln. In this study we wanted to determine whether metabolic changes could be reproduced in VPA\u2010treated patients with epilepsy and whether the results differed from those known in chronic hepatic encephalopathy (CHE).<\/jats:p><jats:p><jats:bold><jats:styled-content>Methods:<\/jats:styled-content>\u2002<\/jats:bold> Seven patients with epilepsy pretreated with VPA and seven healthy volunteers were investigated on a 3T\u2010scanner. We performed proton magnetic resonance spectroscopy (<jats:sup>1<\/jats:sup>H\u2010MRS) using a short echo time point\u2010resolved spectroscopy (PRESS) in the parietal and occipital lobe, respectively. Spectral analysis was performed by LCModel, allowing a separation of Glu and Gln at 3T. Absolute values of <jats:italic>myo<\/jats:italic>\u2010Inositol (mI), choline (Cho), creatine (Cr), <jats:italic>N<\/jats:italic>\u2010acetyl\u2010aspartate (NAA), glutamine (Gln), glutamate (Glu), and the sum of Gln and Glu (Glx) were calculated.<\/jats:p><jats:p><jats:bold><jats:styled-content>Results:<\/jats:styled-content>\u2002<\/jats:bold> In the parietal lobe, mI was significantly decreased in the patients\u2019 group compared to the healthy volunteers. After separation of the signals of Gln and Glu, a significant increase of Gln was observed in the parietal lobe in the patients\u2019 group. No significant differences in the occipital spectra could be observed between the groups.<\/jats:p><jats:p><jats:bold><jats:styled-content>Discussion:<\/jats:styled-content>\u2002<\/jats:bold> In VPA\u2010treated patients the alteration of the Glu\/Gln ratio differs from that in patients with CHE, where Glx is markedly increased because of an increase in Gln. The expected shift from the biochemical balance reaction of Gln\/Glu induced by VPA could be reproduced for the parietal lobe. Significantly reduced mI in the parietal lobe of VPA\u2010treated patients most likely reflects an osmolytic compensation for high Gln.<\/jats:p>","DOI":"10.1111\/j.1528-1167.2008.01801.x","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T14:58:13Z","timestamp":1223305093000},"page":"486-492","source":"Crossref","is-referenced-by-count":26,"title":["Valproate\u2010induced metabolic changes in patients with epilepsy: Assessment with <sup>1<\/sup>H\u2010MRS"],"prefix":"10.1111","volume":"50","author":[{"given":"Meritxell","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans\u2010Juergen","family":"Huppertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sargon","family":"Ziyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Buechert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,4]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"1779","article-title":"Valproic acid\u2010induced hyperammonemic encephalopathy: MR appearance","volume":"15","author":"Baganz MD","year":"1994","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(83)90602-1"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1120\/jacmp.v7i1.2151"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.020203.x"},{"key":"e_1_2_7_6_1","first-page":"251","volume-title":"Lippincott\u2019s illustrated reviews: biochemistry","author":"Champe PC","year":"2005"},{"key":"e_1_2_7_7_1","first-page":"254","volume-title":"Lippincott\u2019s illustrated reviews: biochemistry","author":"Champe PC","year":"2005"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91773-0"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80489-1"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000168485.76397.5c"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.3.467"},{"key":"e_1_2_7_12_1","first-page":"322","volume-title":"Principles of neural science","author":"Kandel ER","year":"2000"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2004.07.013"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)93439-V"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1940040214"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.182.1.1345760"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(05)81955-9"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01228.x"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(98)00075-6"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.3.365"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000138768.61600.ad"},{"key":"e_1_2_7_22_1","first-page":"1019","article-title":"1H\u2010MR spectroscopy, magnetization transfer, and diffusion\u2010weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy","volume":"27","author":"Miese F","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_2_7_23_1","first-page":"50","article-title":"A study for clinical correlation of neuropsychological test and brain magnetic resonance spectroscopy in patients with minimal hepatic encephalopathy","volume":"42","author":"Nam SW","year":"2003","journal-title":"Korean J Gastroenterol"},{"key":"e_1_2_7_24_1","first-page":"746","article-title":"Two cases of valproate\u2010induced hyperammonemic encephalopathy without hepatic failure","volume":"52","author":"Panda S","year":"2004","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/seiz.1999.0267"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.6.673"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910300604"},{"key":"e_1_2_7_28_1","first-page":"450","volume-title":"Goodman and Gilman\u2019s the pharmacology basis of therapeutics","author":"Rall TW","year":"1990"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412448200"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0720-048X(92)90226-Y"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00655.x"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005398516208"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2007.03.001"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2005.10.048"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02098881"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000216682.56067.23"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.2.206"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.1.136-a"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.42201.x"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2008.01801.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1528-1167.2008.01801.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T15:58:58Z","timestamp":1697126338000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2008.01801.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1528-1167.2008.01801.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01801.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}